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ABSTRACT: Successful aging is a multidimensional construct that could be viewed as a continuum of 
achievement. Based on the disability model proposed by the WHO International Classification of 
Functioning, Disability and Health, successful aging includes not only the presence or absence of disease, 
but also aspects of mobility and social participation. Here we review definitions of successful aging and 
discuss relevance of the disability model in the evaluation of successful aging and frailty. In particular, we 
summarize evidences that highlight the importance of measures of mobility (ability to walk and perform 
activities of daily living), and social participation in identifying and locating older adults across the range of 
the successful aging continuum. Lastly, we discuss the role of inflammation in age-related decline and in 
frailty. Future research directions are proposed, including identifying causal pathways among 
inflammatory markers, disability, and frailty. A better understanding of immunological functioning in late 
life may help unlock novel ways to promote successful aging. 
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Over the past century, substantial increases in life 
expectancy and advances in health care and research, 
combined with escalating health care costs, have led to 
great interest in how to promote a healthier old age and 
how to age “successfully.” The goal of aging 
successfully appears increasingly feasible, as evidence 
builds that interventions such as physical activity can 
reduce disability and promote better health in late life, 
and morbidity becomes compressed into a much shorter 
duration  [1, 2]. With observations for increases in total 
life expectancy in recent years, there is considerable 
research interest in the measure of active life expectancy 
(ALE). ALE measures the number of years a person can 
expect to live without disability.  Supporting the concept 
of morbidity compression, recent findings indicate that 
younger cohorts of older adults are living longer with 
less disability [3]. Recent work supports the premise that 
ALE provides valuable information to health care 
professionals and policy makers. For example, while 
neither obesity nor arthritis (alone or in combination) 
was related to length of life for older adults, the 
combination of the two was significantly related to 
decreased ALE, or higher levels of disability [4]. In 
another application, both men and women with 
Alzheimer’s disease exhibited shortened life expectancy 
and spent a greater proportion of their remaining years 
with extensive disability compared to cognitively intact 
peers [5]. Thus, central to the tenet of ALE as a 
component of successful aging is the measurement of 
disability.  
Nevertheless, there is little consensus on the optimal 
definition of successful aging and its measurement. 
There is also no consensus on what term would be used, 
with descriptors ranging from “healthy aging”, “positive 
aging”, “optimal aging” to “aging well”.  This review 
will discuss the definitions of successful aging, the use 
of the disability model in the measurement of successful 
aging, recent evidence linking disability, frailty, and 
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inflammation, and potential future directions for 
research.  
 
Defining successful aging 
 
The concept of successful aging was first introduced by 
Rowe and Kahn [6] and used in the MacArthur Research 
Network on Successful Aging [7]. They offered that 
those aging successfully would show minimal declines in 
physiologic function, while those aging 'usually' would 
show disease-related decrements and loss of reserve 
capacity, commonly interpreted as the effects of age. 
Specifically, they proposed three components of 
successful aging, namely: (a) absence or avoidance of 
disease and risk factors for disease, (b) retaining a high 
level of cognitive function, and (c) active engagement in 
life. Although this is an important model that separates 
the effects of disease from the aging process itself, it 
essentially excludes older adults with any degree of 
incapacity, and focuses on a smaller elite segment of the 
older population that may result in less interest in 
secondary and tertiary lines of prevention.  
 While Rowe and Kahn's biomedical model 
emphasizes the absence of disease as one of the keys to 
successful aging, Baltes and Baltes [8] defined 
successful aging from an ecological perspective. They 
viewed successful aging as the ability to function across 
physical/functional, cognitive, emotional, and social 
domains. They recognized that aging often leads to 
losses or limitation in one or more domains (allowing for 
the presence of chronic disease) and proposed that 
successful aging is the ability to optimize adaptation, i.e. 
making the most of one’s remaining capacities and 
compensating for losses and limitations. Similarly, in 
their definition of successful aging, Vaillant and 
Mukamel [9] describe the importance of physical, social, 
and emotional health.   
 An operational definition of successful aging has 
been elusive. Self-perceived successful aging is much 
more common than Rowe and Kahn might suggest. 
About 50% of older adults in one study self-reported that 
they were aging successfully while only 19% were so 
classified using Rowe and Kahn criteria [10]. Self-
perceived successful aging was nonetheless still related 
to health and function. The proportion who stated they 
were aging successfully declined as the number of 
prevalent medical conditions increased, and was lower in 
those with functional difficulties.  
A recent review of 28 quantitative studies found 29 
different operational definitions of successful aging [11]. 
The lack of a consensus definition presents uncertainty 
about the actual prevalence of successful aging. In the 28 
studies, the mean proportion of successful agers was 
36% but the range was 0.4% to 95%. The range was 
affected by the type of study population; the rates were 
inversely related to lowest eligible age. It was also 
affected by the complexity of the definition of successful 
aging; the rates decreased with the number of 
components in the definition.  
Among the elements in the definition of successful 
aging, disability and/or physical functioning were the 
most frequently used (26 of 29) and were most 
commonly measured by self-reported activities of daily 
living (ADLs). Factors most frequently associated with 
any definition of successful aging included age, non-
smoking, absence of disability, and absence of arthritis, 
diabetes, and hearing problems. While no satisfactory 
definition of successful aging has yet emerged, all 
evidences to date suggest that the presence of disability 
and level of physical functioning are key components of 
any definition. 
 
Disability as a measurement of successful aging 
 
The WHO International Classification of Functioning, 
Disability and Health (ICF) provides a framework to 
describe the impact of health conditions at both 
individual and societal levels [12]. From the ICF 
standpoint, disability is a result of an interaction between 
a person (with a health condition) and that person's 
contextual factors (environmental factors and personal 
factors). Disability denotes all of the following: (a) 
impairments in body functions and structures; (b) 
limitations in activity (individual level); and (c) 
restriction in participation (societal level). Thus, 
disability = A + B + C, and the full picture of disability 
can only be acquired by measuring all three dimensions. 
Impairment information: Anatomical impairment 
alone may not provide a complete picture of the situation 
of disability. Knowing that an individual has loss of 
vision or hearing does not reveal whether these 
impairments affect that person's ability to carry out day-
to-day activities. Further, people with the same 
impairments may experience very different daily life 
restrictions. The converse is also true; people can 
experience the same restrictions even though they have 
different impairments.  
Limitations in Activity: These are typically measured 
by assessing (a) mobility, and (b) both basic and 
instrumental ADLs. Mobility is defined as the ability to 
move one's own body through space, and includes 
activities such as walking, standing up, reaching, turning 
over in bed and climbing stairs [13]. These mobility 
tasks are the building blocks of both basic ADLs (e.g. 
bathing, dressing, eating) and instrumental ADLs (e.g. 
housework, preparing meals, shopping, managing 
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money). Walking, viewed as the fundamental mobility 
task for human life, is a complex neuromotor activity.  
Many variables influence walking speed, including 
musculoskeletal status [14, 15], sensory function [16], 
motor control [17], and cognitive status [18]. There is 
now rich empirical evidence that objective or self-
reported measurement of walking ability in older adults 
is a powerful predictor of future health and mortality. 
Walking ability is typically measured by determining: 
(a) usual walking speed, measured over a distance of 4 or 
8 meters, (b) time to walk 400 meters (approximately 1/4 
mile, or 2 to 3 city blocks), or (c) self-reported ability to 
walk 1/4 mile, rated on a scale ranging from no difficulty 
at all, to unable to walk the distance. The most common 
and practical objective measure of walking ability is 
usual walking speed, typically determined by the time to 
walk 4 or 8 meters, using a stopwatch or an instrumented 
walkway. Usual walking speed in healthy adults 
typically ranges from 1.2 to 1.4 m/s and begins to 
decline in the 5
th
 and 6
th
 decades of life [19].  
In older adults, walking at speeds faster than 1.0 m/s 
has been associated with greater independence in ADLs 
and reduced likelihood of hospitalization and adverse 
events. Conversely, walking at speeds slower than 0.6 
m/s has been associated with dependence in ADLs and 
increased likelihood of hospitalization [20]. Usual 
walking speed has been associated with survival in 
single cohorts [21-23] and a recent pooled analysis of 9 
cohort studies revealed that faster walking speeds are 
associated with improved survival, with significant 
increments in survival per 0.1 m/s [24]. Further, the 
accuracy of predicted survival using only walking speed, 
age and gender has been found to be similar to more 
complex models including health-related factors or 
functional status [24]. These findings support the 
premise that walking speed is a general summary 
indicator that reflects the integrity of various underlying 
physiological processes.  
Higher-level mobility includes the ability to go 
outside the home without help, the ability to walk longer 
distances such as 1/4 mile (400 meters), and the ability to 
climb stairs. Higher-level mobility disability has been 
defined as an inability or difficulty with walking 1/4 mile 
[13]. Slower 400-meter walk times have been associated 
with a higher risk of mortality [25, 26] and older adults 
who needed to stop and rest during the 400-meter walk 
were more likely to develop future mobility disability 
[27]. Similar to actual performance, self-reported 
limitations in walking 1/4 mile were associated with 
subsequent mortality, development of disability, and 
increased hospitalizations and health care costs [28].   
Reports of limitations in functional abilities 
(activities of daily living or ADLs) are also associated 
with adverse outcomes. Older adults who were 
dependent on personal assistance for ADLs had the 
highest probability of admission to a skilled-nursing 
facility and highest probability of death, followed by 
those who reported being independent but had difficulty 
[29]. Older adults who reported no difficulty with ADLs 
exhibited the lowest probabilities of adverse outcomes. 
Similarly, ADL performance upon admission to a 
nursing home strongly predicted 3-year mortality [30].  
Clearly, physical performance, and self-reported 
measures of mobility and ADL are simple, brief, and 
cost-effective methods that characterize an individual’s 
limitations in activity. They provide estimates of future 
risk for hospitalization and mortality, and may be used to 
screen older adults in clinical settings.  
Restriction in Participation:Participation restriction 
is defined as “problems an individual may experience in 
involvement in life situations"[12]. It refers to the 
negative personal and social consequences of health 
conditions. While it might be expected that limitations in 
activity are a major cause of participation restriction (e.g. 
difficulty in walking leads to restrictions in leaving the 
home), personal and environmental factors may worsen 
or lessen the effects of activity limitations, or cause 
restrictions in older adults who have no or minimal 
limitations [31]. For example, an older adult may 
initially walk faster than 1.0 m/s and be independent in 
ADLs. But with lack of transportation or finances, he/she 
may be restricted in leaving their home. This restriction 
could ultimately lead to a decline in mobility and health. 
Likewise, an older woman with minimal impairments 
and activity limitations who provides care to her 
dependent spouse could be restricted to her home. These 
types of issues have led to a growing interest in the 
investigation of participation restriction in older adults. 
A cross-sectional survey revealed that that the health 
and disability factors most strongly associated with 
participation restriction were the number of health 
conditions, presence of pain, cognitive impairment, 
depression and activity limitation [31]. After adjusting 
for these factors, perceived adequacy of income, 
employment status, and occupational class were also 
strongly associated with participation restriction. 
Interestingly, 14% of responders classified at the highest 
level of activity limitation did not report any 
participation restriction. These findings suggest that 
while activity limitation and participation restriction are 
strongly related, participation restriction is a distinct 
concept influenced by a wide range of health and socio-
economic factors.  
Researchers investigating the natural history of 
participation restriction over 3 years in people aged 50 
years and older found that overall participation was 
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unchanged in ~ 70% of the sample, and changed in 30% 
[32]. Nearly 30% of those free from restriction at 
baseline reported restriction in at least one aspect of life 
3 years later, whereas 30% of those who had a restriction 
at baseline reported being free from restrictions 3 years 
later. The oldest age-group had both higher incidence 
and persistence of participation restriction. The most 
common form of restriction evident even in the young-
old was restricted mobility outside the home. These 
findings indicate that participation restriction naturally 
fluctuates over time with periods of incidence and 
recovery, and that restrictions begin first with mobility 
outside the home.  
Recently, the Late Life Function and Disability 
Instrument (LLFDI) [33, 34] was used to examine what 
variables contributed to self-reported frequency of 
involvement versus perceived restriction [35]. 
Participation frequency questions are phrased, “How 
often do you do...?”, whereas perceived restriction 
questions are phrased “To what extent do you feel 
limited in doing…?”. The authors found that age, fall 
history, and general physical activity levels were 
strongly associated with participation frequency, 
whereas mobility variables had the strongest associations 
with perceived restriction. Depressive symptoms were 
associated with both reduced frequency of involvement 
and more restrictions.  
All the above findings highlight the complex 
relationships between health, mobility, and participation. 
Therefore, a definition of successful aging needs to 
consider a multidimensional construct, rather than a 
count of incident diseases or conditions. Rather than 
classifying an older adult as successful or unsuccessful, 
aging may be viewed as a continuum of achievement. 
Individuals with few activity limitations and 
participation restrictions may be on the “more 
successful” end of the continuum, whereas individuals 
with greater limitations and restrictions may be on the 
“less successful” end; that is, all the components of 
disability (impairments, limitations in activity, 
participation restriction) should be considered when 
locating an older adult on the continuum. Additionally, 
the findings from the participation restriction literature 
suggest that this continuum is not unidirectional. Rather, 
successful aging is dynamic, and individuals can move 
either way on the continuum. For example, a high-
functioning older adult who undergoes a joint 
replacement or suffers a mild stroke may temporarily 
experience slow, painful gait, an inability to leave their 
home unassisted, and depression. But following 
rehabilitation and a recovery period, he/she may return to 
their previous status. While there is no current consensus 
on the critical parameters or minimal criteria for good or 
bad physical function, usual walking speed and/or self-
reported measures of walking ability and ADL status can 
be used to identify and locate older adults across the 
range of the continuum [20, 24, 28]. By monitoring these 
tasks over time, clinicians can detect change and initiate 
appropriate treatments to prevent decline or restore 
function. Thus, one important challenge to researchers 
and health care providers is to monitor and detect older 
adults at increased risk of disability. An important state 
that is distinct from normal aging and a strong risk factor 
for disability is the clinical syndrome of frailty [36]. 
 
Frailty 
 
In clinical practice, the syndrome of frailty identifies the 
most vulnerable subset of older adults at increased risk 
for adverse outcomes and requiring enhanced care.  In 
the United States, it is estimated that frailty affects 7% of 
the population age ≥ 65 years, and 25-40% of those ≥ 80 
years [36], with a majority of nursing home residents 
identified as frail [37]. A recent Canadian study reported 
the percentage of deaths due to frailty was similar to 
percentages due to sudden death, terminal illness, or 
organ failure, and the health care costs for frailty in the 
last two years of life were similar to those for patients 
with cancer or organ failure [38]. Thus, the impact of 
frailty is significant for the individual, his/her immediate 
family, and the society at large.  
Frail older adults are often assumed to be disabled, 
and have multiple chronic conditions or comorbidity. 
Recent research supports the premise that frailty, 
comorbidity, and disability are not synonymous terms, 
but describe distinct, yet interrelated entities. One-
quarter of older patients show signs of frailty without 
multiple comorbidities or disability that makes them 
dependent on others or outside services [39]. It has also 
been demonstrated that there is not a linear path from 
comorbidity through disability to frailty; rather, frailty 
may either be the cause or the consequence of disability 
[40]. While frailty is a commonly used term in clinical 
practice, it remains an evolving concept that has neither 
consensus definition nor unique diagnostic criteria [41].  
In general, frailty describes a subset of older adults 
who are at risk of adverse events due to reduced ability 
to respond to stress [41]. A research group led by Fried 
et al. [36, 42] described frailty as a state of global 
deficiency of physiological reserves and functional 
dysregulation involving multiple organ systems, 
resulting in poor homeostasis and increased vulnerability 
when faced with stressors. They defined a frailty 
phenotype as a clinical syndrome characterized by 
shrinking (unintentional weight loss and 
sarcopenia/muscle wasting), weakness, exhaustion or 
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poor endurance, slow walking speed, and reduced overall 
activity. Presence of three or more of the criteria was 
defined as positive for the frailty phenotype, whereas 
individuals with one or two of criteria are considered 
“pre-frail”.  
Based on data from the Cardiovascular Health Study 
(CHS), the frailty phenotype independently predicted 
incident falls, ADL disability, hospitalization and death, 
and prefrail status showed intermediate risk of adverse 
outcomes as well as increased risk of becoming frail 
[36]. Using this CHS frailty phenotype criteria, a recent 
study classified 48% of residents of assisted living 
facilities as frail, finding these individuals at greater risk 
for death (adjusted risk ratio 1.75) and hospitalization 
(adjusted risk ratio 1.54) [43]. Although research using 
this CHS frailty phenotype consistently supports its 
ability to predict poorer outcomes, one limitation is that 
items used to identify frailty are all measures of physical 
health without due consideration of cognitive 
performance or emotional status. 
Another working group led by Rockwood et al. 
defined frailty as an at-risk state caused by the age-
associated accumulation of deficits [44]. Deficits cover a 
whole range of health problems, and can be in the form 
of symptoms, signs, clinical laboratory abnormalities, 
and incident diseases or disabilities. Deficits are counted 
and combined in a “Frailty Index”, determined from a 
comprehensive geriatric assessment of multiple domains 
including cognition, mood, motivation, communication, 
mobility, balance, ADL, bowel and bladder functions, 
nutrition, comorbidities, and social resources [45, 46]. 
The premise is that as older adults accumulate more 
deficits, they are at more risk and become more frail. 
Across studies, increasing values of the frailty index are 
highly associated with an increased risk of death. When 
both frailty index and age are combined in a 
multivariable model, frailty index has predicted mortality 
better than age [45, 47, 48]. 
 From the ICF disability framework perspective, 
frailty is linked with both participation restriction and 
limitations in activity (mobility). In a study of 
community-dwelling adults who met the criteria for the 
CHS frailty phenotype, 80% reported participation 
restriction in at least one aspect of their lives [49]. And 
such participation restriction is independently associated 
with mobility, as 51% reported restricted community 
mobility.  
Several recent studies have examined the relation 
between frailty status and mobility. Higher Frailty Index 
scores (more deficits) were associated with poorer 
performance on physical performance measures, 
including a timed walk test, but only at the very upper 
range of index scores did all participants demonstrate 
some mobility impairment [50]. In a cohort study of 
community-dwelling adults, those classified as having 
good baseline mobility (based on a timed fast walking 
test) had greater probability of improvement or stability 
of the Frailty Index over a 36 and 54 month follow up 
compared to those with poor baseline mobility [51]. 
These data suggest interactions between frailty, mobility, 
and participation restriction, supporting the premise that 
frail older adults are less mobile and more restricted 
[51].  
Just as frailty is a syndrome reflecting the function of 
many systems, usual walking speed is also a general 
summary indicator reflective of the integrity of multiple 
underlying physiological processes. Given that slow 
walking speed is one of the five criteria for the CHS 
frailty phenotype, gait speed could be a useful single-
item screening tool to identify frail older adults, with a 
proposed threshold speed of 0.8 m/s [52, 53]. While the 
pathophysiologic mechanisms underlying the frailty 
process are not yet fully understood, both the phenotypic 
and deficit accumulation definitions of frailty recognize 
the involvement of multiple systems. The most 
commonly suggested impairments involve dysregulation 
or loss of redundancy in neuromuscular, endocrine, and 
inflammatory systems.  
 
Role of inflammation in age-related decline and in 
frailty 
 
The serum levels of the inflammatory markers 
interleukin (IL)-6, IL-1, tumor necrosis factor (TNF)-, 
and C-reactive protein (CRP) have been found to 
increase with age. Although neither the sources of these 
molecules nor the cause for their systemic upregulation 
are known, higher quartiles of inflammatory markers 
have been associated with, and predict poorer outcomes 
in older adults, and are consistently associated with 
cardiovascular disease, diabetes, cancer, and all-cause 
mortality (see thorough review by Singh and Newman 
2011)[54]. In addition to these associations with multiple 
chronic diseases, there is a growing body of research 
about the associations among inflammatory markers, 
mobility and disability.  
Higher levels of IL-6 have been associated with 
poorer physical performance measures, including slower 
walking speeds, poorer standing balance, and longer 
times to complete repeated chair stands [55, 56]. In a 
large prospective study, circulating levels of IL-6 greater 
than 2.5 pg/mL predicted future mobility disability 
(walking 1/2 mile or climbing stairs) in older adults who 
had no disability at baseline [57]. Similarly, data from 
the Women’s Health and Aging Study (WHAS) showed 
that older women in the highest IL-6 tertiles had higher 
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relative risks of mobility disability and severe limitations 
in walking compared with those in the lowest tertile, 
even after adjusting for age [58]. In the Health, Aging, 
and Body Composition (Health ABC) study, higher 
levels of IL-6, TNF- and CRP predicted incident 
mobility limitation (difficulty or inability to walk 1/4 
mile) over 30 months independent of disease and illness 
[59], and that individuals with elevated levels of all three 
markers had the highest incidence of mobility limitation. 
Further, the onset of disability is generally preceded by 
elevation of inflammatory markers [60, 61]. 
There is a growing body of evidence linking 
inflammation and frailty. Frail older adults exhibit higher 
levels of CRP [62] and IL-6 [63], and higher CRP levels 
are associated with an increased risk for development of 
frailty [64]. With increasing patient frailty (as defined by 
the CHS frailty phenotype and the Frailty Index of 
accumulated deficits), levels of TNF-, IL-6, and CRP 
increase significantly, suggesting the association with 
inflammation does not depend on the specific definition 
of frailty [65]. 
One explanation for the associations among 
inflammation, mobility decline, and frailty is the effects 
that inflammatory markers have on muscles. CRP, IL-6 
and TNF- receptor-2 levels are negatively correlated 
with rate of skeletal muscle protein synthesis [66], 
indicating that inflammation participates in the 
development of sarcopenia, which is defined as a loss of 
muscle mass and strength leading to functional 
alterations [67]. Higher combined levels of IL-6 and 
TNF- are associated with smaller muscle area, less 
muscle mass, and lower knee and grip strength [68]. In 
an InCHIANTI study, IL-6 independently predicted grip 
strength and muscle power [69], and in the Framingham 
Heart Study, IL-6 predicted loss of fat free mass [70]. In 
the previously mentioned WHAS study, when the hazard 
models for risk of mobility disability and severe 
limitations in walking were adjusted for change in knee 
strength over time, the association between high IL-6 
and decline of physical function was substantially 
reduced, suggesting that one mechanism underlying the 
development of disability in these women with high IL-6 
serum levels is the effect of IL-6 on muscle strength 
[58].  
As sarcopenia is a major component of the CHS 
frailty phenotype, it has been proposed that inflammation 
in these individuals is related to sarcopenia rather than to 
frailty itself [65]. Further, sarcopenia may lead to 
changes in body composition and abdominal adiposity, 
which in turn is associated with insulin-resistance. 
Insulin-resistance is associated with an increased risk for 
the development of frailty [64].  
However, causal relationships between IL-6, TNF-, 
and other inflammatory markers, and muscle wasting, or 
frailty in general, have yet to be proven. While IL-6 
appears a stronger predictor of muscle weakness, only 
TNF- has been shown to elicit muscle cell cytolysis in 
vitro and in animal models [71, 72]. An important 
cautionary note is that during normal chronologic aging 
and in the setting of frailty, the levels of inflammatory 
markers found in serum are at low picogram-quantities, 
hence the term “low-grade inflammation” [73]. This is in 
stark contrast to much higher microgram/milligram-
levels of systemic cytokines found in young patients 
with chronic inflammatory diseases such as rheumatoid 
arthritis and systemic lupus erythematosus [74, 75], yet 
such patients do not exhibit the clinical features of 
sarcopenia and frailty. Another important consideration 
is the pleiotropic effects of cytokines [76]. And although 
both IL-6 and TNF- have clear inflammatory effects, 
they are also required for normal antibody-mediated and 
cell-mediated protective immune responses, respectively.  
Therefore, an important question that has yet to be 
examined is the level at which IL-6 or TNF- cause 
muscle wasting or sarcopenia. Alternatively, low levels 
of systemic IL-6 and TNF- could simply be surrogate 
markers of ongoing age-related declines in various 
physiologic systems. And a counter intuitive but equally 
reasonable, possibility is that such low levels of systemic 
upregulation of cytokines might represent a unique 
physiologic environment wherein novel processes of 
homeostasis operate in old age. A case in point are 
centenarians who have been found to express more than 
twice the level of plasma IL-6 compared to 65-80 year 
olds, and yet such centenarians are functionally 
independent [77]. Clearly, there is much room for further 
investigation into the role of inflammatory molecules in 
the elaboration of the frailty phenotype in particular, and 
in health and performance outcomes in old age in 
general. 
 
Gaps in knowledge and future directions for research 
  
All the above findings indicate that successful aging is a 
multidimensional construct. Viewed from the ICF 
disability model [12] successful aging includes not only 
the presence or absence of disease, but also aspects of 
mobility and social participation. Thus, in order to 
pursue gaps in knowledge about underlying mechanisms 
and to translate insights into novel interventions, we 
suggest consideration of a spectrum of successful aging. 
Among more successfully aging older adults, a 
mechanistic research focus could be to identify factors 
which promote resilience from age-related frailty, while 
research in clinical translation could focus on 
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interventions that prevent, or substantially delay, 
functional decline. For the more frail, a mechanistic 
research focus could be on the dynamics of multiple 
system dysregulation, and a clinical research focus could 
be on novel interventions to promote recovery and 
increased tolerance to stress.  
An important clinical translation study is a proposal 
for the development of standards for IL-6 serum levels 
that could be useful in medical practice [58], perhaps in 
the diagnosis of frailty and in prognosticating functional 
independence or dependence. Considering the consistent 
finding for the inverse relationship between IL-6, 
physical ability, incident disease, and mortality [54], a 
tantalizing idea is whether IL-6 neutralization might be 
clinically useful in improving health and function of 
older adults. Parenthetically, there currently are anti-IL-6 
therapies that are clinically used in the treatment of 
inflammatory diseases such as rheumatoid arthritis and 
Castleman’s disease [78, 79]. A research challenge is to 
determine whether such therapies would be safe for use 
among older adults who might otherwise have no 
inflammatory disease.    
A key gap in knowledge is to clarify causal pathways 
among inflammatory markers, incident disease, 
disability, and frailty. One approach is to examine 
immunological responses to an intervention such as 
vaccination. Frail elders respond more poorly to 
vaccination compared to the less frail [80]. Thus, 
reduced vaccination responsiveness suggests that the 
frailty state might represent a distinctive 
immunosuppressed phenotype of aging.  
An intervention that is known to promote health in 
aging is physical exercise. Resistance exercise training is 
known to improve muscle function and mobility in both 
healthy and frail older adults [81-83]. Multi-component 
exercise programs (usually focused on resistance, 
balance, aerobic, and flexibility training) have been 
shown to improve mobility [84], balance confidence 
[85], and blood lipid profiles [86]; they also reduce fall 
risk and fall rate [87], as well as improve quality of life 
[88].  
One mechanism of benefit of physical exercise 
appears to be related to its effects in down modulating 
inflammatory markers. High levels of recreational 
activity have been associated with lower levels of 
inflammatory markers among high-functioning older 
adults [89]. In community-dwelling older men, those 
with self-reported light and moderate physical activity 
levels had lower levels of inflammatory markers than 
those who were sedentary [90]. More recently, the effect 
of exercise on inflammatory markers has been assessed 
in clinical trials. The Lifestyle Interventions and 
Independence for Elders (LIFE) Trial demonstrated that 
a 12-month structured physical activity program lowered 
IL-6 levels in community-dwelling older adults, and this 
effect was most pronounced in individuals with the 
greatest risk of disability [91].  
Thus, both observational and clinical trial evidence 
shows strong association between physical activity and 
inflammatory state. Future research in this area could 
focus on the signaling pathways linking exercise to the 
control or attenuation of inflammation, and on the types 
of exercise that best promote healthy immune aging in 
successful agers and in frail older persons. A better 
understanding of immunological functioning in late life 
may help unlock novel ways to promote successful 
aging. This could be facilitated by building a shared 
vocabulary about the age-related states of health, 
functioning, and frailty and applying it consistently to 
studies of inflammation and immunity.  
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